In order to move forward, it is expected that existing data from the Phase 2b/3 Anavex 2-73 AD-004 program be submitted to the FDA. In December, as expected, the CHMP adopted a negative opinion on the ...
Legacy Academic Services Revenue -- $55 million in Q4, with the segment now managed specifically for free cash flow generation. Free Cash Flow -- Negative $15 million in Q4, primarily impacted by $12 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results